2023-2029 Global Complicated Skin and Skin Structure Infections Drugs Industry Research & Trends Analysis Report
According to YH Research, the global market for Complicated Skin and Skin Structure Infections Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Complicated Skin and Skin Structure Infections Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Complicated Skin and Skin Structure Infections Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Tedizolid segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Complicated Skin and Skin Structure Infections Drugs include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann-La Roche Ltd and Pfizer Inc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Skin and skin structure infections are among the most common bacterial infection of skin-related tissues. The increased antimicrobial resistance among both gram-positive and gram-negative bacteria is a rapidly growing reason for hospitalization in complicated skin structural infections. Skin structural infections are usually considered complicated in case of needed surgery combined with antimicrobial therapy. The complicated skin structural infections generally include burns, ulcers, and major underlying diseases that complicate antibiotic treatment. The major symptoms of skin and skin structure infections include pus, blisters, skin sloughing, breakdown, and skin being discolored and painful.
This report aims to provide a comprehensive study of the global market for Complicated Skin and Skin Structure Infections Drugs. Report Highlights:
(1) Global Complicated Skin and Skin Structure Infections Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Complicated Skin and Skin Structure Infections Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Complicated Skin and Skin Structure Infections Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Complicated Skin and Skin Structure Infections Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Complicated Skin and Skin Structure Infections Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Complicated Skin and Skin Structure Infections Drugs, capacity, production and trends.
(7) Complicated Skin and Skin Structure Infections Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Tedizolid
Vancomycin
Ceftaroline
Linezolid
Darbavansing
Olivanstar
Tedizolid
Market segment by application, can be divided into
Hospital
Specialist Clinic
Home Care
Other
Market segment by players, this report covers
Novartis AG
Endo International Inc
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Inc
Dr Reddy's Laboratories Ltd
Abbott
F. Hoffmann-La Roche Ltd
Pfizer Inc
Zydus Group
Lupin
Melinta Therapeutics, Inc
MerLion Pharmaceuticals GmbH
Paratek Pharmaceuticals, Inc
1 Market Overview
1.1 Complicated Skin and Skin Structure Infections Drugs Definition
1.2 Global Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast
1.2.1 By Revenue, Global Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
1.2.3 Global Complicated Skin and Skin Structure Infections Drugs Price Trend, 2018-2029
1.3 China Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast
1.3.1 By Revenue, China Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
1.3.3 China Complicated Skin and Skin Structure Infections Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Complicated Skin and Skin Structure Infections Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Complicated Skin and Skin Structure Infections Drugs Share in Global Market, 2018-2029
1.4.3 Complicated Skin and Skin Structure Infections Drugs Market Size: China VS Global, 2018-2029
1.5 Complicated Skin and Skin Structure Infections Drugs Market Dynamics
1.5.1 Complicated Skin and Skin Structure Infections Drugs Market Drivers
1.5.2 Complicated Skin and Skin Structure Infections Drugs Market Restraints
1.5.3 Complicated Skin and Skin Structure Infections Drugs Industry Trends
1.5.4 Complicated Skin and Skin Structure Infections Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Complicated Skin and Skin Structure Infections Drugs Revenue by Company, 2018-2023
2.2 Global Complicated Skin and Skin Structure Infections Drugs Sales Volume by Company, 2018-2023
2.3 Global Complicated Skin and Skin Structure Infections Drugs Price by Company, 2018-2023
2.4 Global Complicated Skin and Skin Structure Infections Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Complicated Skin and Skin Structure Infections Drugs Concentration Ratio
2.6 Global Complicated Skin and Skin Structure Infections Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Complicated Skin and Skin Structure Infections Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Complicated Skin and Skin Structure Infections Drugs Revenue by Company, 2018-2023
3.2 China Complicated Skin and Skin Structure Infections Drugs Sales Volume by Company, 2018-2023
3.3 China Complicated Skin and Skin Structure Infections Drugs Complicated Skin and Skin Structure Infections Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Complicated Skin and Skin Structure Infections Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Complicated Skin and Skin Structure Infections Drugs Domestic VS Export
3.6 China Market, Complicated Skin and Skin Structure Infections Drugs Import & Export
3.6.1 China Market, Complicated Skin and Skin Structure Infections Drugs Import & Export, 2018-2029
3.6.2 China Complicated Skin and Skin Structure Infections Drugs Import & Export Trends
3.6.3 Main Sources of China Complicated Skin and Skin Structure Infections Drugs Import
3.6.4 Export Destination of China Complicated Skin and Skin Structure Infections Drugs
4 Complicated Skin and Skin Structure Infections Drugs Production by Region
4.1 Global Complicated Skin and Skin Structure Infections Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Complicated Skin and Skin Structure Infections Drugs Manufacturers
4.3 Global Major Manufacturers, Complicated Skin and Skin Structure Infections Drugs Capacity Expansion and Future Plans
4.4 Global Complicated Skin and Skin Structure Infections Drugs Capacity by Region
4.5 Global Complicated Skin and Skin Structure Infections Drugs Production by Region
4.5.1 Global Complicated Skin and Skin Structure Infections Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Complicated Skin and Skin Structure Infections Drugs Production by Region, 2018-2023
4.5.3 Global Complicated Skin and Skin Structure Infections Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Complicated Skin and Skin Structure Infections Drugs Industry Chain
5.2 Complicated Skin and Skin Structure Infections Drugs Upstream Analysis
5.2.1 Complicated Skin and Skin Structure Infections Drugs Core Raw Materials
5.2.2 Main Manufacturers of Complicated Skin and Skin Structure Infections Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Complicated Skin and Skin Structure Infections Drugs Production Mode
5.6 Complicated Skin and Skin Structure Infections Drugs Procurement Model
5.7 Complicated Skin and Skin Structure Infections Drugs Industry Sales Model and Sales Channels
5.7.1 Complicated Skin and Skin Structure Infections Drugs Sales Model
5.7.2 Complicated Skin and Skin Structure Infections Drugs Typical Distributors
6 Sights by Type
6.1 Complicated Skin and Skin Structure Infections Drugs Classification
6.1.1 Tedizolid
6.1.2 Vancomycin
6.1.3 Ceftaroline
6.1.4 Linezolid
6.1.5 Darbavansing
6.1.6 Olivanstar
6.1.7 Tedizolid
6.2 By Type, Global Complicated Skin and Skin Structure Infections Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029
6.4 By Type, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029
6.5 By Type, Global Complicated Skin and Skin Structure Infections Drugs Price, 2018-2029
7 Sights by Application
7.1 Complicated Skin and Skin Structure Infections Drugs Segment by Application
7.1.1 Hospital
7.1.2 Specialist Clinic
7.1.3 Home Care
7.1.4 Other
7.2 By Application, Global Complicated Skin and Skin Structure Infections Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029
7.4 By Application, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029
7.5 By Application, Global Complicated Skin and Skin Structure Infections Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Complicated Skin and Skin Structure Infections Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029
8.3 By Region, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Complicated Skin and Skin Structure Infections Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Complicated Skin and Skin Structure Infections Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Complicated Skin and Skin Structure Infections Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.7 South America
8.7.1 South America Complicated Skin and Skin Structure Infections Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Complicated Skin and Skin Structure Infections Drugs Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029
9.3 By Country, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.6.2 By Company, China Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.10.2 By Company, India Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis AG
10.1.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.1.2 Novartis AG Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.1.3 Novartis AG Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis AG Company Profile and Main Business
10.1.5 Novartis AG Recent Developments
10.2 Endo International Inc
10.2.1 Endo International Inc Company Information, Head Office, Market Area and Industry Position
10.2.2 Endo International Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.2.3 Endo International Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Endo International Inc Company Profile and Main Business
10.2.5 Endo International Inc Recent Developments
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.3.2 Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.3.3 Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.4 Glenmark Pharmaceuticals Ltd
10.4.1 Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
10.4.2 Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.4.3 Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Glenmark Pharmaceuticals Ltd Company Profile and Main Business
10.4.5 Glenmark Pharmaceuticals Ltd Recent Developments
10.5 Cipla Inc
10.5.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.5.2 Cipla Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.5.3 Cipla Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cipla Inc Company Profile and Main Business
10.5.5 Cipla Inc Recent Developments
10.6 Dr Reddy's Laboratories Ltd
10.6.1 Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
10.6.2 Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.6.3 Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Dr Reddy's Laboratories Ltd Company Profile and Main Business
10.6.5 Dr Reddy's Laboratories Ltd Recent Developments
10.7 Abbott
10.7.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.7.2 Abbott Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.7.3 Abbott Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abbott Company Profile and Main Business
10.7.5 Abbott Recent Developments
10.8 F. Hoffmann-La Roche Ltd
10.8.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.8.2 F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.8.3 F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.8.5 F. Hoffmann-La Roche Ltd Recent Developments
10.9 Pfizer Inc
10.9.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.9.2 Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.9.3 Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Pfizer Inc Company Profile and Main Business
10.9.5 Pfizer Inc Recent Developments
10.10 Zydus Group
10.10.1 Zydus Group Company Information, Head Office, Market Area and Industry Position
10.10.2 Zydus Group Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.10.3 Zydus Group Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Zydus Group Company Profile and Main Business
10.10.5 Zydus Group Recent Developments
10.11 Lupin
10.11.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.11.2 Lupin Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.11.3 Lupin Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Lupin Company Profile and Main Business
10.11.5 Lupin Recent Developments
10.12 Melinta Therapeutics, Inc
10.12.1 Melinta Therapeutics, Inc Company Information, Head Office, Market Area and Industry Position
10.12.2 Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.12.3 Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Melinta Therapeutics, Inc Company Profile and Main Business
10.12.5 Melinta Therapeutics, Inc Recent Developments
10.13 MerLion Pharmaceuticals GmbH
10.13.1 MerLion Pharmaceuticals GmbH Company Information, Head Office, Market Area and Industry Position
10.13.2 MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.13.3 MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 MerLion Pharmaceuticals GmbH Company Profile and Main Business
10.13.5 MerLion Pharmaceuticals GmbH Recent Developments
10.14 Paratek Pharmaceuticals, Inc
10.14.1 Paratek Pharmaceuticals, Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
10.14.3 Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Paratek Pharmaceuticals, Inc Company Profile and Main Business
10.14.5 Paratek Pharmaceuticals, Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Complicated Skin and Skin Structure Infections Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Complicated Skin and Skin Structure Infections Drugs Market Restraints
Table 3. Complicated Skin and Skin Structure Infections Drugs Market Trends
Table 4. Complicated Skin and Skin Structure Infections Drugs Industry Policy
Table 5. Global Complicated Skin and Skin Structure Infections Drugs Revenue by Company, 2018-2023, US$ million
Table 6. Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share by Company, 2018-2023
Table 7. Global Complicated Skin and Skin Structure Infections Drugs Sales Volume by Company, 2018-2023, (Tons)
Table 8. Global Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share by Company, 2018-2023
Table 9. Global Complicated Skin and Skin Structure Infections Drugs Price by Company, 2018-2023, (US$/Ton)
Table 10. Global Complicated Skin and Skin Structure Infections Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Complicated Skin and Skin Structure Infections Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Complicated Skin and Skin Structure Infections Drugs Manufacturers Product Type
Table 13. China Complicated Skin and Skin Structure Infections Drugs Revenue by Company, 2018-2023, US$ million
Table 14. China Complicated Skin and Skin Structure Infections Drugs Revenue Market Share by Company, 2018-2023
Table 15. China Complicated Skin and Skin Structure Infections Drugs Sales Volume by Company, 2018-2023, (Tons)
Table 16. China Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Complicated Skin and Skin Structure Infections Drugs Production, Sales, Import and Export, 2018-2029, (Tons)
Table 18. China Complicated Skin and Skin Structure Infections Drugs Import & Export Trends
Table 19. Main Sources of China Complicated Skin and Skin Structure Infections Drugs Import
Table 20. Export Destination of China Complicated Skin and Skin Structure Infections Drugs
Table 21. Global Headquarters and Manufacturing Base of Complicated Skin and Skin Structure Infections Drugs Manufacturers
Table 22. Global Major Manufacturers, Complicated Skin and Skin Structure Infections Drugs Capacity Expansion and Future Plans
Table 23. Global Complicated Skin and Skin Structure Infections Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 24. Global Complicated Skin and Skin Structure Infections Drugs Production by Region, 2018-2023, (Tons)
Table 25. Global Complicated Skin and Skin Structure Infections Drugs Production Forecast by Region, 2023-2029, (Tons)
Table 26. Global Key Players of Complicated Skin and Skin Structure Infections Drugs Upstream (Raw Materials)
Table 27. Global Complicated Skin and Skin Structure Infections Drugs Typical Customers
Table 28. Complicated Skin and Skin Structure Infections Drugs Typical Distributors
Table 29. By Type, Global Complicated Skin and Skin Structure Infections Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Complicated Skin and Skin Structure Infections Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Complicated Skin and Skin Structure Infections Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Table 34. By Country, Global Complicated Skin and Skin Structure Infections Drugs Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2018-2029
Table 37. By Country, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Table 38. By Country, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2018-2029
Table 39. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 40. Novartis AG Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 41. Novartis AG Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Novartis AG Company Profile and Main Business
Table 43. Novartis AG Recent Developments
Table 44. Endo International Inc Company Information, Head Office, Market Area and Industry Position
Table 45. Endo International Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 46. Endo International Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Endo International Inc Company Profile and Main Business
Table 48. Endo International Inc Recent Developments
Table 49. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 50. Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 51. Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 53. Teva Pharmaceutical Industries Ltd Recent Developments
Table 54. Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 56. Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Glenmark Pharmaceuticals Ltd Company Profile and Main Business
Table 58. Glenmark Pharmaceuticals Ltd Recent Developments
Table 59. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 60. Cipla Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 61. Cipla Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Cipla Inc Company Profile and Main Business
Table 63. Cipla Inc Recent Developments
Table 64. Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
Table 65. Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 66. Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Dr Reddy's Laboratories Ltd Company Profile and Main Business
Table 68. Dr Reddy's Laboratories Ltd Recent Developments
Table 69. Abbott Company Information, Head Office, Market Area and Industry Position
Table 70. Abbott Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 71. Abbott Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Abbott Company Profile and Main Business
Table 73. Abbott Recent Developments
Table 74. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 75. F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 76. F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 78. F. Hoffmann-La Roche Ltd Recent Developments
Table 79. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 80. Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 81. Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Pfizer Inc Company Profile and Main Business
Table 83. Pfizer Inc Recent Developments
Table 84. Zydus Group Company Information, Head Office, Market Area and Industry Position
Table 85. Zydus Group Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 86. Zydus Group Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. Zydus Group Company Profile and Main Business
Table 88. Zydus Group Recent Developments
Table 89. Lupin Company Information, Head Office, Market Area and Industry Position
Table 90. Lupin Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 91. Lupin Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Lupin Company Profile and Main Business
Table 93. Lupin Recent Developments
Table 94. Melinta Therapeutics, Inc Company Information, Head Office, Market Area and Industry Position
Table 95. Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 96. Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. Melinta Therapeutics, Inc Company Profile and Main Business
Table 98. Melinta Therapeutics, Inc Recent Developments
Table 99. MerLion Pharmaceuticals GmbH Company Information, Head Office, Market Area and Industry Position
Table 100. MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 101. MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 102. MerLion Pharmaceuticals GmbH Company Profile and Main Business
Table 103. MerLion Pharmaceuticals GmbH Recent Developments
Table 104. Paratek Pharmaceuticals, Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications and Application
Table 106. Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Sales Volume (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 107. Paratek Pharmaceuticals, Inc Company Profile and Main Business
Table 108. Paratek Pharmaceuticals, Inc Recent Developments
List of Figure
Figure 1. Complicated Skin and Skin Structure Infections Drugs Picture
Figure 2. By Revenue, Global Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast, 2018-2029, (Tons)
Figure 4. Global Complicated Skin and Skin Structure Infections Drugs Price Trend, 2018-2029, (US$/Ton)
Figure 5. By Revenue, China Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast, 2018-2029, (Tons)
Figure 7. China Complicated Skin and Skin Structure Infections Drugs Price Trend, 2018-2029 (US$/Ton)
Figure 8. By Revenue, China Complicated Skin and Skin Structure Infections Drugs Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Complicated Skin and Skin Structure Infections Drugs Share of Global Market, 2018-2029
Figure 10. Global Complicated Skin and Skin Structure Infections Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Complicated Skin and Skin Structure Infections Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Complicated Skin and Skin Structure Infections Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Complicated Skin and Skin Structure Infections Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Complicated Skin and Skin Structure Infections Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Complicated Skin and Skin Structure Infections Drugs Domestic VS Export, 2022
Figure 16. Global Complicated Skin and Skin Structure Infections Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Complicated Skin and Skin Structure Infections Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Complicated Skin and Skin Structure Infections Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 19. Complicated Skin and Skin Structure Infections Drugs Industry Chain
Figure 20. Complicated Skin and Skin Structure Infections Drugs Procurement Model
Figure 21. Complicated Skin and Skin Structure Infections Drugs Sales Model
Figure 22. Complicated Skin and Skin Structure Infections Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Tedizolid
Figure 24. Vancomycin
Figure 25. Ceftaroline
Figure 26. Linezolid
Figure 27. Darbavansing
Figure 28. Olivanstar
Figure 29. Tedizolid
Figure 30. By Type, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029, US$ Million
Figure 31. By Type, Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2018-2029
Figure 32. By Type, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 33. By Type, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2018-2029
Figure 34. By Type, Global Complicated Skin and Skin Structure Infections Drugs Price, 2018-2029, (US$/Ton)
Figure 35. Hospital
Figure 36. Specialist Clinic
Figure 37. Home Care
Figure 38. Other
Figure 39. By Application, Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2018-2029, US$ Million
Figure 40. By Application, Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2018-2029
Figure 41. By Application, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 42. By Application, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2018-2029
Figure 43. By Application, Global Complicated Skin and Skin Structure Infections Drugs Price, 2018-2029, (US$/Ton)
Figure 44. By Region, Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2018-2029
Figure 45. By Region, Global Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2018-2029
Figure 46. North America Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, North America Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2022
Figure 48. Europe Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, Europe Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2022
Figure 50. Asia Pacific Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. By Country/Region, Asia Pacific Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2022
Figure 52. South America Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 53. By Country, South America Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2022
Figure 54. Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 55. U.S. Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 56. By Company, U.S. Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 57. By Type, U.S. Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, U.S. Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 59. Europe Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 60. By Company, Europe Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 61. By Type, Europe Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, Europe Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 63. China Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 64. By Company, China Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 65. By Type, China Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, China Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 67. Japan Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 68. By Company, Japan Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 69. By Type, Japan Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, Japan Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 71. South Korea Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 72. By Company, South Korea Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 73. By Type, South Korea Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, South Korea Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 75. Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 76. By Company, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 77. By Type, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 79. India Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 80. By Company, India Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 81. By Type, India Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, India Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 83. Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume, 2018-2029, (Tons)
Figure 84. By Company, Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Market Share, 2022
Figure 85. By Type, Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 86. By Application, Middle East & Asia Complicated Skin and Skin Structure Infections Drugs Sales Volume Market Share, 2022 VS 2029
Figure 87. Research Methodology
Figure 88. Breakdown of Primary Interviews
Figure 89. Bottom-up Approaches
Figure 90. Top-down Approaches
Reason to Buy
- Current and future of Chemical & Material Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Chemical & Material Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets